Sign inGet started

McKee Blaine H.

Insider CIK 1669133 · HART Director · VBIV Director · IMGN EVP & Chief Business Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VBIV VBI Vaccines Inc/BC A Award deriv2023-07-272023-07-2835,000— $035,000SEC↗
VBIV VBI Vaccines Inc/BC A Award deriv2023-01-262023-01-3050,000— $050,000SEC↗
VBIV VBI Vaccines Inc/BC A Award deriv2022-01-272022-01-3175,000— $075,000SEC↗
VBIV VBI Vaccines Inc/BC A Award deriv2021-01-272021-01-2975,000— $075,000SEC↗
VBIV VBI Vaccines Inc/BC A Award deriv2020-01-222020-01-24250,000— $0250,000SEC↗
IMGN IMMUNOGEN INC A Award2019-07-012019-07-025,230$1.84 $9.6K5,230SEC↗
IMGN IMMUNOGEN INC A Award deriv2019-01-312019-02-04173,140$5.25 $909.0K173,140SEC↗
VBIV VBI Vaccines Inc/BC A Award deriv2019-01-312019-02-04300,000— $0300,000SEC↗
BSTG Biostage, Inc. M Exercise deriv2018-03-142018-03-28912— $00SEC↗
BSTG Biostage, Inc. M Exercise2018-03-142018-03-28912— $0912SEC↗
BSTG Biostage, Inc. A Award deriv2017-03-142017-03-1618,250— $018,250SEC↗
BSTG Biostage, Inc. A Award deriv2017-03-142017-03-1625,000— $025,000SEC↗
HART Harvard Apparatus Regenera A Award deriv2016-03-222016-03-2425,000— $025,000SEC↗
HART Harvard Apparatus Regenera A Award deriv2016-03-152016-03-1725,000— $025,000SEC↗